Rights and permissions
About this article
Cite this article
NICE issues draft guidance on abiraterone for prostate cancer. Pharmacoecon. Outcomes News 647, 10 (2012). https://doi.org/10.2165/00151234-201206470-00030
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206470-00030